Back to Cymra Life Sciences or All Oil Concentrates

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This product was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Medication Details

Brand
Cymra Life Sciences
Designation
Cybis T10:C25
THC Potential Range (10% Legal Variance)
10mg
CBD Potential Range (10% Legal Variance)
25mg
Cultivated or Packaged in
Australia Flag of Australia

Stock Availability

We provide stock and pharmacy information for medical cannabis patients only. Cannabis is a controlled substance in the UK and can only be dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed here.

Best Known Status: Unavailable

Main Importer/Distributor (Authoritative Stock)

Dispensing Pharmacies

Product DescriptionPatient Reviews

Australia About Cymra Life Sciences Ltd.

Cymra Life Sciences is an Australian owned licenced and permitted cultivator and manufacturer of medical cannabis from the Australian Office of Drug Control.

We've set out to cultivate full spectrum medicines to enhance the lives of people living in chronic and neuropathic pain.

We are focused on the development of cannabis medicines for chronic and neuropathic pain.

WHY? We don’t believe there is good long term medication options for chronic pain conditions (i.e opiates) are a good long term medication and have serious side effects.

We’re one of the first Australian companies to develop medical cannabis through tissue culture propagation, a method which delivers a consistent, natural product, free from pests and chemical dependencies. The team at Cymra Life Sciences is innovative, ambitious and fast-moving, all backed up by years of experience across pain management, medical research, plant genetics and breeding.

Patient Reviews

Coming soon, this feature is currently under active development.

  Prescription cannabis patients struggling with affordability should be allowed to grow their own, as in Canadian Flag Canada and many American Flag American states. Agree? Sign the Government Petition.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)